ATE26918T1 - Topische pharmazeutische zusammensetzungen. - Google Patents

Topische pharmazeutische zusammensetzungen.

Info

Publication number
ATE26918T1
ATE26918T1 AT83300531T AT83300531T ATE26918T1 AT E26918 T1 ATE26918 T1 AT E26918T1 AT 83300531 T AT83300531 T AT 83300531T AT 83300531 T AT83300531 T AT 83300531T AT E26918 T1 ATE26918 T1 AT E26918T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
substances capable
inhibiting
lesions
Prior art date
Application number
AT83300531T
Other languages
English (en)
Inventor
David Frederick Horrobin
Julian Lieb
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Ltd filed Critical Efamol Ltd
Application granted granted Critical
Publication of ATE26918T1 publication Critical patent/ATE26918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT83300531T 1982-02-03 1983-02-02 Topische pharmazeutische zusammensetzungen. ATE26918T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34520482A 1982-02-03 1982-02-03
EP83300531A EP0085579B1 (de) 1982-02-03 1983-02-02 Topische pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE26918T1 true ATE26918T1 (de) 1987-05-15

Family

ID=23354027

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83300531T ATE26918T1 (de) 1982-02-03 1983-02-02 Topische pharmazeutische zusammensetzungen.

Country Status (7)

Country Link
EP (1) EP0085579B1 (de)
JP (1) JPH0714873B2 (de)
AT (1) ATE26918T1 (de)
AU (1) AU556817B2 (de)
DE (1) DE3371282D1 (de)
FI (1) FI830360L (de)
ZA (1) ZA83685B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194185B (it) * 1983-04-01 1988-09-14 Schiapparelli Farma Composizione per il trattamento dell'acne
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
JPS60130519A (ja) * 1983-12-16 1985-07-12 Terumo Corp 脂肪輸液剤
GB8420771D0 (en) * 1984-08-15 1984-09-19 Efamol Ltd Treatment of skin disorders
GB8524276D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
GB8719988D0 (en) * 1987-08-25 1987-09-30 Efamol Ltd Chemical compounds
DE3863678D1 (de) * 1987-04-27 1991-08-22 Efamol Holdings Lithiumsalze enthaltende pharmazeutische zubereitungen.
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
EP0432700A3 (de) * 1987-08-25 1991-06-26 Efamol Holdings Plc Verwendung von Lithium-Verbindungen zur Behandlung von "combination skin"
JPH01135704A (ja) * 1987-11-18 1989-05-29 Medical Res Internatl Ltd 微生物を破壊する表面処理方法
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
GB9211229D0 (en) * 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
FR2694692B1 (fr) * 1992-08-13 1994-10-28 Thorel Jean Noel Préparation cosmétique de nutrition de la peau.
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
US5756107A (en) * 1994-12-21 1998-05-26 Cosmederm Technologies Formulations and methods for reducing skin irritation
CA2210856A1 (en) * 1995-01-18 1996-07-25 Taisho Pharmaceutical Co., Ltd. Dermatitis-curing agent
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
CN1213757C (zh) * 1999-12-30 2005-08-10 亨德森莫利研究和开发有限公司 Dna病毒感染的协同治疗
JP4880813B2 (ja) * 2000-10-26 2012-02-22 第一三共株式会社 外用消炎鎮痛剤組成物
BR0204228A (pt) * 2001-02-20 2004-06-22 Randy Ziegler Métodos para melhorar os sintomas de uma psicose e de esquizofrenia e para triar moléculas de teste, e, composto orgânico
EP1426059A4 (de) * 2001-09-14 2007-01-17 Ono Pharmaceutical Co Mittel zur behandlung von pruritus
US8258181B2 (en) * 2005-03-23 2012-09-04 Florida Atlantic University Treatment or prevention of cancer and precancerous disorders
EP1967187B1 (de) * 2007-03-06 2011-04-06 Rachid Ennamany Zusammensetzung auf Basis von Rutin und L-Lysin
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2013521300A (ja) * 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
EP2708230B1 (de) * 2011-05-12 2024-10-02 Nissui Corporation Zusammensetzung zur äusserlichen anwendung auf der haut für entzündliche erkrankungen
ES2872449T3 (es) 2013-12-04 2021-11-02 Nippon Suisan Kaisha Ltd Aceite microbiano, procedimiento para fabricar aceite microbiano, aceite microbiano concentrado y procedimiento para fabricar aceite microbiano concentrado

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639625A (en) * 1967-07-13 1972-02-01 Lewis Sherwin Compositions containing lithium succinate
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
EP0012115A1 (de) * 1978-12-04 1980-06-11 Ciba-Geigy Ag Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
JPS56125313A (en) * 1980-03-09 1981-10-01 Lion Corp Remedy for damage
JPS56125312A (en) * 1980-03-09 1981-10-01 Lion Corp Remedy for damage
JPH0233013B2 (ja) * 1980-03-21 1990-07-25 Masatoshi Fumiiri Sokonchiryozai
JPS56161323A (en) * 1980-05-14 1981-12-11 Hisamitsu Pharmaceut Co Inc Anti-inflammatory and pain-killing gel
US4328243A (en) * 1981-04-07 1982-05-04 Horrobin David F Manic-depressive illnesses
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor

Also Published As

Publication number Publication date
FI830360A0 (fi) 1983-02-02
AU556817B2 (en) 1986-11-20
AU1087583A (en) 1983-08-11
FI830360A7 (fi) 1983-08-04
EP0085579B1 (de) 1987-05-06
DE3371282D1 (en) 1987-06-11
JPS58208217A (ja) 1983-12-03
FI830360L (fi) 1983-08-04
JPH0714873B2 (ja) 1995-02-22
EP0085579A3 (en) 1984-02-29
ZA83685B (en) 1984-04-25
EP0085579A2 (de) 1983-08-10

Similar Documents

Publication Publication Date Title
AU556817B2 (en) Topical application of a lithium salt and dihomo-alpha- linolenic acid
ES482778A0 (es) Un procedimiento para la preparacion de una composicion u- til en el tratamiento de la epidermis.
IT8019118A0 (it) Apparecchio manuale per la cura o il trattamento dei denti.
SE8902377D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
IT7928079A0 (it) Dispositivo per interventi chirurgici in cavita' del corpo umano.
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
AU4926690A (en) Oxidized diphenylheteroalkanes, the preparation and use thereof
ZA793234B (en) Indole derivatives and their use as antianxiety drugs or sedatives
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IT8023101A0 (it) Composizione farmaceutica per uso terapeutico, per uso diagnostico e quale integratore alimentare.
SE7708642L (sv) 1,5-disubstituerade pyrrolidoner och forfaranden for framstellning derav
FR2599933B3 (fr) Appareil pour derouler les bottes de fourrage, conditionnees sous forme de rouleaux.
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IL57609A0 (en) Pharmaceutical agents for the treatment of sickle cell disease comprising aromatic aminoacid derivatives
AU6366780A (en) 5-(2-hydroxystyryl)-isoxazole derivatives
PH16621A (en) New 2,3-dihydro-4-pyrone derivatives,the herbicidal composition in which they are present,and their use for selectively destroying weeds in crops
GB2060638B (en) Lysine and arginine 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid salts pharmaceutical compositions containing them and their use
IT1166217B (it) Composizione farmaceutica per la terapia delle sterilita' maschile
BE783775A (fr) La prothese dentaire chez l'edente total.
IT7921153A0 (it) Prodotti microbicidi e procedimento per la loro preparazione.
ATE9700T1 (de) (n-phosphonoacetyl-l-aspartato) (1,2diaminocyclohexan)-platin (ii) und natrium-, kalium- oder lithiumsalze, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
RO80227A2 (ro) Medicament utilizat in profilaxia retentiilor placentare nespecifice la taurine
NO882494D0 (no) Ex vivo effektorcelleaktivering for maalcelledreping.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee